Gene ID | Gene Name | Gene Symbol | Disease Ontology ▲ |
---|---|---|---|
130420964 | mannose-P-dolichol utilization defect 1b |
|
|
130414120 | UDP-glucuronosyltransferase 2A1-like |
|
|
130426957 | xylosyltransferase I |
|
|
130409582 | UDP glycosyltransferase 8 |
|
|
130435240 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
|
|
130421280 | glycogen synthase 2 |
|
|
130440080 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
|
|
130426546 | UDP glucuronosyltransferase 5 family, polypeptide G1 |
|
|
130426761 | LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
|
130408966 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3 |
|
|
130425748 | uncharacterized LOC130425748 |
|
|
130420870 | beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
|
|
130427661 | UDP-glucose glycoprotein glucosyltransferase 2 |
|
|
130434878 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
|
|
130420881 | carbohydrate (chondroitin 4) sulfotransferase 11 |
|
|
130432940 | beta-1,4-galactosyltransferase 3 |
|
|
130439809 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5b |
|
|
130413389 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11) |
|
|
130420509 | transmembrane O-mannosyltransferase targeting cadherins 2a |
|
|
130428623 | alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase a |
|
|
130413036 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 |
|
|
130420921 | glucoside xylosyltransferase 1b |
|
|
130439192 | carbohydrate sulfotransferase 15-like |
|
|
130412969 | glycogenin 1b |
|
|
130417799 | carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2a |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024